Tobramycin solution

FDA Drug Profile — Tobramycin

Tobramycin solution is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Tobramycin. Available dosage form: inhalant.

Drug details

Generic Name
Tobramycin solution
Brand Names
Tobramycin
Application Number
ANDA217344
Sponsor
Micro Labs Limited
NDC Codes
1
Dosage Forms
INHALANT
Routes
RESPIRATORY (INHALATION)
Active Ingredients
TOBRAMYCIN

Indications and Usage

1 INDICATIONS AND USAGE Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV 1 ) <25% or >75% predicted, or patients colonized with Burkholderia cepacia [see Clinical Studies ( 14 )]. Tobramycin inhalation solution is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . ( 1 ) Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV1) <25% or >75% predicted, or patients colonized with Burkholderia cepacia. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.